ProfileGDS4718 / 236837_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 3% 36% 1% 17% 39% 44% 6% 5% 16% 18% 7% 21% 56% 39% 8% 15% 45% 35% 19% 9% 13% 17% 19% 14% 31% 17% 52% 8% 45% 22% 42% 12% 12% 46% 55% 29% 7% 2% 35% 9% 56% 18% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0645818
GSM549102patient 115, normal, homogenized [OPG study]3.488823
GSM549104patient 119, normal, homogenized [OPG study]4.7737836
GSM549108patient 138, normal, homogenized [OPG study]3.350751
GSM549119patient 077, normal, homogenized [OPG study]4.0394517
GSM549133patient 032, cancer, homogenized [OPG study]4.9104439
GSM549139patient 042, cancer, homogenized [OPG study]5.1516444
GSM549099patient 107, normal, homogenized [OPG study]3.611686
GSM549109patient 139, normal, homogenized [OPG study]3.595065
GSM549110patient 046, normal, homogenized [OPG study]4.0000516
GSM549114patient 063, normal, homogenized [OPG study]4.0330618
GSM549122patient 082, normal, homogenized [OPG study]3.663457
GSM549134patient 033, cancer, homogenized [OPG study]4.1835721
GSM549136patient 036, cancer, homogenized [OPG study]5.8574756
GSM549140patient 044, cancer, homogenized [OPG study]4.9255539
GSM549111patient 047, normal, homogenized [OPG study]3.686768
GSM549113patient 057, normal, homogenized [OPG study]3.9277115
GSM549132patient 031, cancer, homogenized [OPG study]5.2349145
GSM549137patient 038, cancer, homogenized [OPG study]4.7519835
GSM549142patient 047, cancer, homogenized [OPG study]4.1882319
GSM549100patient 110, normal, homogenized [OPG study]3.752179
GSM549107patient 135, normal, homogenized [OPG study]3.8693513
GSM549115patient 068, normal, homogenized [OPG study]4.0032217
GSM549116patient 072, normal, homogenized [OPG study]4.0750819
GSM549120patient 078, normal, homogenized [OPG study]3.9301214
GSM549131patient 030, cancer, homogenized [OPG study]4.5116431
GSM549118patient 074, normal, homogenized [OPG study]4.0457817
GSM549129patient 027, cancer, homogenized [OPG study]5.6234652
GSM549123patient 088, normal, homogenized [OPG study]3.727058
GSM549124patient 006, cancer, homogenized [OPG study]5.3022945
GSM549126patient 015, cancer, homogenized [OPG study]4.2287222
GSM549128patient 025, cancer, homogenized [OPG study]5.0444142
GSM549103patient 117, normal, homogenized [OPG study]3.8634812
GSM549117patient 073, normal, homogenized [OPG study]3.8558612
GSM549138patient 041, cancer, homogenized [OPG study]5.2752346
GSM549141patient 045, cancer, homogenized [OPG study]5.784355
GSM549130patient 028, cancer, homogenized [OPG study]4.5112229
GSM549101patient 111, normal, homogenized [OPG study]3.666587
GSM549105patient 128, normal, homogenized [OPG study]3.420752
GSM549106patient 134, normal, homogenized [OPG study]4.699935
GSM549112patient 048, normal, homogenized [OPG study]3.752159
GSM549125patient 011, cancer, homogenized [OPG study]5.8480656
GSM549127patient 024, cancer, homogenized [OPG study]4.0520218
GSM549135patient 035, cancer, homogenized [OPG study]5.7771455